Antony Pfaffle is Chief Scientific Officer at CorMedix Inc. (CRMD). They have made 13 open-market trades across 1 company since 2011, most recently 2017-02-07.
CIK 0001410098
1 open-market purchase totalling $640 since 2011, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CRMD | 10,000 | $57K |
Shares reported on the most recent Form 4, priced at the 2017-02-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRMD | SELL · 10b5-1 | 2017-02-07 | 2017-02-08 | $2.00 | $20K | +3.7% | -1.9% | -75.7% |
| CRMD | SELL · 10b5-1 | 2016-10-21 | 2016-10-25 | $2.23 | $45K | -3.3% | -16.0% | -21.1% |
| CRMD | SELL | 2016-06-20 | 2016-06-22 | $2.13 | $127K | -8.3% | -24.9% | +41.0% |
| CRMD | SELL | 2016-06-15 | 2016-06-16 | $2.21 | $11K | -12.4% | -23.0% | -1.8% |
| CRMD | SELL | 2016-06-10 | 2016-06-14 | $2.27 | $12K | -9.9% | -17.9% | -9.0% |
| CRMD | SELL | 2016-06-09 | 2016-06-13 | $2.38 | $24K | -4.6% | -22.2% | -10.6% |
| CRMD | SELL | 2016-05-24 | 2016-05-25 | $2.74 | $21K | -9.8% | -35.7% | -46.1% |
| CRMD | SELL | 2016-05-20 | 2016-05-24 | $2.89 | $85K | -3.5% | -27.7% | -40.7% |
| CRMD | SELL | 2016-05-18 | 2016-05-20 | $2.82 | $35K | -4.9% | -21.1% | -41.8% |
| CRMD | SELL | 2016-05-13 | 2016-05-17 | $2.63 | $105K | -3.4% | -26.6% | -38.9% |
| CRMD | SELL | 2016-05-13 | 2016-05-17 | $2.70 | $203K | -3.4% | -26.6% | -38.9% |
| CRMD | SELL | 2015-06-01 | 2015-06-03 | $6.37 | $191K | -32.3% | -4.0% | -4.0% |
| CRMD | SELL | 2015-05-13 | 2015-05-15 | $6.49 | $109K | -32.3% | -4.0% | -4.0% |
| CRMD | SELL | 2013-09-24 | 2013-09-30 | $0.92 | $115 | -32.3% | -4.0% | -4.0% |
| CRMD | BUY | 2011-12-15 | 2011-12-19 | $0.32 | $640 | -32.3% | -4.0% | -4.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.